LAUSR

References 1 Regli A, Becke K, von Ungern-Sternberg BS. An update on the perioperative management of children with upper respiratory tract infections. Curr Opin Anaesthesiol 2017; 30:362–367. 2 Habre W, Disma N, Virag K, et al. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med 2017; 5:412–425. 3 von Ungern-Sternberg BS, Boda K, Chambers NA, et al. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet 2010; 376:773–783. 4 Michel F, Vacher T, Julien-Marsollier F, et al. Peri-operative respiratory adverse events in children with upper respiratory tract infections allowed to proceed with anaesthesia: a French national cohort study. Eur J Anaesthesiol 2018; 35:919–928. 5 Austin PC. The performance of different propensity-score methods for estimating relative risks. J Clin Epidemiol 2008; 61:537–545. 6 Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir Med 2007; 101:685–695. 7 Volovitz B, Bilavsky E, Nussinovitch M. Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. J Asthma 2008; 45:561– 567. 8 Singhi S, Banerjee S, Nanjundaswamy H. Inhaled budesonide in acute asthma. J Paediatr Child Health 1999; 35:483–487.